On Jun. 28, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, awarded $26 million to fund clinical research that aims to address a variety of cancers, heart conditions, and rare diseases.

The awards will support five projects in the Agency’s clinical program, which provides funding for eligible stem cell and gene therapy-based projects through all stages of clinical trial development.